Neurocrine Biosciences
NBIX
#1592
Rank
HK$81.65 B
Marketcap
HK$819.01
Share price
-4.92%
Change (1 day)
-24.44%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : HK$8.77 Billion

According to Neurocrine Biosciences 's latest financial reports the company's total liabilities are HK$8.77 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Neurocrine Biosciences - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$8.76 B10.09%
2023-12-31HK$7.96 B54.18%
2022-12-31HK$5.16 B-5.19%
2021-12-31HK$5.44 B15.46%
2020-12-31HK$4.71 B-9.48%
2019-12-31HK$5.21 B29.87%
2018-12-31HK$4.01 B15.29%
2017-12-31HK$3.48 B793.88%
2016-12-31HK$0.38 B-0.19%
2015-12-31HK$0.39 B46.48%
2014-12-31HK$0.26 B0.23%
2013-12-31HK$0.26 B-17.61%
2012-12-31HK$0.32 B-46.96%
2011-12-31HK$0.60 B-37.53%
2010-12-31HK$0.97 B87.75%
2009-12-31HK$0.51 B-17.59%
2008-12-31HK$0.62 B-48.92%
2007-12-31HK$1.23 B111.25%
2006-12-31HK$0.58 B-19.16%
2005-12-31HK$0.72 B-25.99%
2004-12-31HK$0.97 B-23.27%
2003-12-31HK$1.26 B285.1%
2002-12-31HK$0.32 B17.61%
2001-12-31HK$0.28 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
HK$6.32 B-27.90%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$61.22 B 597.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$83.06 M-99.05%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$500.71 B 5,608.00%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.024 T 11,573.78%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$970.44 B 10,962.80%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$6.64 B-24.25%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.34 B-96.12%๐Ÿ‡บ๐Ÿ‡ธ USA